Clinical Trials on Chronic Graft-versus-host Disease (cGVHD) in United Kingdom
Total 1711 results
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedGraft-Versus-Host DiseaseUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
University of Michigan Rogel Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnGraft-versus-host Disease PreventionUnited States
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Masonic Cancer Center, University of MinnesotaRecruitingAcute-graft-versus-host DiseaseUnited States
-
Jonsson Comprehensive Cancer CenterWithdrawnAcute Graft Versus Host Disease | Gastrointestinal Tract Acute Graft Versus Host Disease | Severe Gastrointestinal Tract Acute Graft Versus Host Disease | Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host DiseaseUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnAcute Graft Versus Host Disease | Intestinal Graft Versus Host DiseaseUnited States
-
National Cancer Institute (NCI)RecruitingChronic Graft vs. Host DiseaseUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedGraft Versus Host DiseaseUnited States, United Kingdom, Austria, Germany
-
Hannah Choe, MDNational Cancer Institute (NCI); PlexxikonTerminatedAcute Graft Versus Host Disease | Steroid Refractory Graft Versus Host DiseaseUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoAstex Pharmaceuticals, Inc.CompletedGraft vs Host DiseaseUnited States
-
Dana-Farber Cancer InstitutePrometheus LaboratoriesActive, not recruitingChronic Graft-versus-host-diseaseUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prometheus LaboratoriesActive, not recruitingChronic Graft-versus-host DiseaseUnited States
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
Washington University School of MedicineCompletedGraft Vs Host Disease | Graft-versus-host-diseaseUnited States
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Dartmouth-Hitchcock Medical CenterTerminatedChronic Graft-versus-host-diseaseUnited States
-
University of UtahIncyte CorporationTerminatedChronic Graft-versus-host-diseaseUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedGraft Vs Host DiseaseUnited States
-
AbgenixSangstat Medical CorporationCompletedGraft Vs Host DiseaseUnited States
-
Genentech, Inc.Completed
-
MedImmune LLCCompletedCancer | Graft-Versus-Host DiseaseUnited States
-
Massachusetts General HospitalThe Leukemia and Lymphoma SocietyRecruitingAllogeneic Stem Cell Transplant | Chronic Graft-Versus-Host DiseaseUnited States
-
AltruBio Inc.CompletedSteroid-refractory Acute Graft-versus-Host Disease | Treatment-refractory Acute Graft-versus-Host DiseaseUnited States
-
Washington University School of MedicineGlaxoSmithKline; American Cancer Society, Inc.CompletedGraft Vs Host Disease | Graft-versus-host-diseaseUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingAcute Graft-versus-Host Disease | Allogeneic Stem Cell TransplantUnited States
-
SCRI Development Innovations, LLCIncyte CorporationTerminatedChronic Graft-versus-host-diseaseUnited States
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Sameem M. Abedin, MDRecruitingGraft-versus-host DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedGraft-Versus-Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedGraft-Versus-Host-DiseaseUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedGraft-versus-Host DiseaseUnited States
-
M.D. Anderson Cancer CenterAmgenTerminated
-
Ann & Robert H Lurie Children's Hospital of ChicagoUnknownGraft-Versus-Host DiseaseUnited States
-
Kadmon, a Sanofi CompanyActive, not recruitingChronic Graft-versus-host-diseaseUnited States
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Medical College of WisconsinRecruitingGraft-versus-host DiseaseUnited States
-
NYU Langone HealthRecruiting
-
NYU Langone HealthActive, not recruitingGraft-versus-host DiseaseUnited States
-
National Cancer Institute (NCI)CompletedGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Masonic Cancer Center, University of MinnesotaTerminatedCytokine Release Syndrome | Immune and Microbial Reconstitution | Systemic Viral Infection | Acute-graft-versus-host Disease | Chronic Graft-versus-host-disease | Recurrent Malignancy | Allogenic Related Donors | Cell Therapy/Immunotherapy PatientsUnited States
-
Therakos, Inc., a Mallinckrodt CompanyTerminatedSteroid Refractory Acute Graft Versus Host DiseaseUnited States, Spain, France, Austria, Germany, Hungary, Italy, United Kingdom
-
National Eye Institute (NEI)CompletedGraft-Versus-Host DiseaseUnited States
-
Ladan EspandarWithdrawnGraft-versus-host DiseaseUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
University of Michigan Rogel Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseUnited States